We have started the New Year on a good foot, thanks to some of the milestones and successes our team has achieved over 2024.
We have expanded our technical and advisory team, we published a key high impact paper as a result of a new clinical collaboration, another one of our patents was granted, we were awarded a Best Technology in Spine Award 2024 by neuro and spine surgeons, and we have manufactured the first clinical-grade nanoclay!
This last milestone particularly stands out in our journey to clinical translation of synthetic nanoclays, which are typically industrial materials.
Over the last year, our scientists embarked on the challenge of translating the manufacturing process for our patented RENOVITE® nanoclay into the clean-room environment. As a result, we have an established clinical-grade manufacturing process, tight control over any impurities, and a consistent RENOVITE® nanoclay product.
Our team in the clean-room during the manufacturing of our clinical-grade nanoclay.
Early in my career, I got the exciting opportunity to manufacture our first clinical-grade nanoclay batches in cleanroom facilities—an important milestone for the company. Starting with pharma-grade ingredients, the process ensured strict quality control, resulting in a highly reproducible and consistent product.
-Himanshi Mishra, R&D Chemist
As we move into GLP testing and meet further development milestones, ensuring our RENOVITE® product is easy to handle and complies with clinicians’ requirements is always on the forefront of our mind. Our extensive testing confirms the high-quality RENOVITE® carrier will provide optimal handling for surgeons. Watch this space!
It’s been rewarding to work on refining our product design to meet clinical needs while also integrating manufacturing processes into our Quality Management System. By aligning these elements, we’re ensuring the creation of a product that’s not only clinically effective but also reliable and scalable for future clinical use.
-Roxanna Ramnarine-Sanchez, R&D Lead Scientist
With these major milestones having been completed, the Renovos team is looking forward to a productive 2025!
